Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Rumbaugh

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of the American Chemical Society|May 5, 2020
Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect SplicingJonathan L Chen, Peiyuan Zhang, Masahito Abe, et al.
Nature Neuroscience|November 9, 2023
Non-synaptic function of the autism spectrum disorder-associated gene SYNGAP1 in cortical neurogenesisMarcella Birtele, Ashley Del Dosso, Tiantian Xu, et al.
Molecular Psychiatry|May 31, 2019
MicroRNA regulation of persistent stress-enhanced memoryStephanie E Daws, Sarah Jamieson, Laurence de Nijs, et al.
Cell|June 11, 2025
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastomaRajappa S Kenchappa, Laszlo Radnai, Erica J Young, et al.
ACS Chemical Biology|September 24, 2021
Discovery of Selective Inhibitors for <i>In Vitro</i> and <i>In Vivo</i> Interrogation of Skeletal Myosin IILaszlo Radnai, Matthew Surman, Madalyn Hafenbreidel, et al.
Molecular Psychiatry|June 30, 2019
Correction: MicroRNA regulation of persistent stress-enhanced memoryStephanie E Daws, Sarah Jamieson, Laurence de Nijs, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2007
Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humansYe Wu, Amy C Arai, Gavin Rumbaugh, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
Cell|July 2, 2025
Development of clinically viable non-muscle myosin II small molecule inhibitorsLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
American Journal of Medical Genetics. Part A|December 12, 2019
The sixth international RASopathies symposium: Precision medicine-From promise to practiceKaren W Gripp, Lisa Schill, Lisa Schoyer, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of the American Chemical Society|May 5, 2020
Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect SplicingJonathan L Chen, Peiyuan Zhang, Masahito Abe, et al.
Nature Neuroscience|November 9, 2023
Non-synaptic function of the autism spectrum disorder-associated gene SYNGAP1 in cortical neurogenesisMarcella Birtele, Ashley Del Dosso, Tiantian Xu, et al.
Molecular Psychiatry|May 31, 2019
MicroRNA regulation of persistent stress-enhanced memoryStephanie E Daws, Sarah Jamieson, Laurence de Nijs, et al.
Cell|June 11, 2025
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastomaRajappa S Kenchappa, Laszlo Radnai, Erica J Young, et al.
ACS Chemical Biology|September 24, 2021
Discovery of Selective Inhibitors for <i>In Vitro</i> and <i>In Vivo</i> Interrogation of Skeletal Myosin IILaszlo Radnai, Matthew Surman, Madalyn Hafenbreidel, et al.
Molecular Psychiatry|June 30, 2019
Correction: MicroRNA regulation of persistent stress-enhanced memoryStephanie E Daws, Sarah Jamieson, Laurence de Nijs, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2007
Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humansYe Wu, Amy C Arai, Gavin Rumbaugh, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
Cell|July 2, 2025
Development of clinically viable non-muscle myosin II small molecule inhibitorsLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
American Journal of Medical Genetics. Part A|December 12, 2019
The sixth international RASopathies symposium: Precision medicine-From promise to practiceKaren W Gripp, Lisa Schill, Lisa Schoyer, et al.
Pageof 9